IBC Announces Keynote and Session Lineup for Assays & Cellular Targets (ACT) Conference & Exhibition

IBC announced today the keynote presenter lineup and conference agenda for its upcoming Assays & Cellular Targets (ACT) 2006 conference, to be held October 30 - November 1 at the Green Valley Ranch Resorts in Las Vegas, NV. The conference provides learning and networking opportunities for discovery groups, assay developers, screeners and technology innovation groups in pharmaceutical and biotechnology companies, academia and government.

Keynote Presenters Include:

* Dr. Jeremy Caldwell, Genomics Institute of the Novartis Research
Foundation
* Dr. Thomas Sakmar, Rockefeller University
* Dr. Graeme Milligan, University of Glasgow
* Dr. Eberhard Krausz, Max Planck Institute of Molecular Cell Biology
and Genetics
* Dr. Krzysztof Palczewski, Case Western Reserve University
* Dr. Tomi Sawyer, Ariad Pharmaceuticals

The conference includes 4 conferences and 2 half-day symposia:

--  G-Protein Coupled Receptors conference illustrating why GPCR targets
    are still the most sought after targets in the industry.
--  Assay Development & Cell-Based Assays offering the latest proven
    strategies and techniques for turning  hits to leads to candidates.
--  High Content Analysis conference highlights emerging applications and
    the latest trends in high content analysis for advancing discovery efforts.
--  Protein Kinase Targets conference will uncover the immense potential
    of protein kinase targets.
--  2 half-day symposia on Data Analysis for High Content Screening and
    ADME/Discovery Tox Assays which will cover how  to enhance discovery
    efforts by understanding how to overcome the bottlenecks in data analysis,
    and how to reduce attrition and advance compounds through earlier ADME/Tox
    studies in drug discovery
    

Download the Assays & Cellular Targets (ACT) 2006 event brochure http://www.ibclifesciences.com/scripts/download.asp?PID=D3206&mar=EM&downloadtype=brochure&exd=11%2F1%2F2006&product_title=ACT+2006

For complete information on the program, visit: http://www.IBCLifeSciences.com/ACT

To obtain a press pass for this event or to arrange an interview with a speaker, contact Allison Rigels at (212) 661-3500 x 3237.

IBC Life Sciences is the worldwide leader in scientific, technological and business conferences and courses for the life science industry. To develop its programs, IBC actively researches the advancements, technologies and trends impacting and driving the race for new drugs and therapies. No other organization can make claim to the breadth and quality that IBC Life Sciences delivers in each event giving the company recognition around the globe for quality, service and value. http://www.IBCLifeSciences.com.